ABthrax TM

Related by string. * : Sciences ABthrax Albuferon . ABthrax raxibacumab . any ABthrax doses . ABthrax doses . ABthrax . ABthrax meets / TMD . Tm . TMs . TMS . tm : FinancialWire tm website . Contact FinancialWire tm . TM EA SPORTS . Forrester Wave TM . Ibis T# TM Biosensor . Xerox Phaser TM . Addressing Psoriasis TM . Nintendo GameCube TM . Citrix Synergy TM * ABthrax TM raxibacumab *

Related by context. All words. (Click for frequent words.) 67 IMVAMUNE TM 65 AVP #D# 65 SparVax 65 rPA anthrax vaccine 64 IMVAMUNE 63 Submits Response 63 Adjuvanted 63 Protexia 63 Development Authority BARDA 62 anthrax monoclonal antibody 62 Thiovir 62 hepatitis C lupus 62 CCR5 mAb 62 Fast Track Status 62 Receive Milestone Payment 61 Begins Dosing 61 Protexia R 61 Initiates Clinical 61 raxibacumab 61 PentaStaph 61 recombinant anthrax 61 Valortim TM 61 Bioral Amphotericin B 61 RiVax 61 Pafuramidine 61 FluINsure 60 lucinactant 60 Anthim 60 Neumune 60 VLP vaccine candidate 60 apricitabine ATC 60 SCIB1 60 TKM Ebola 60 Anidulafungin 60 MVA BN R 60 Imvamune 60 GlaxoSmithKline Biologicals GSK 60 bioterrorist weapon 60 Somatuline Depot 59 influenza antivirals 59 Panflu 59 Immunotherapeutic 59 Staphylococcus aureus Polysaccharide Conjugate 59 ACAM# 59 oral prodrug 59 Therapeutic Competitors companiesandmarkets.com adEgemonye 59 neuraminidase inhibitor 59 HHSN#C 59 biodefense pathogens 59 antigen rPA anthrax 59 HCV polymerase 59 IMVAMUNE ® 59 MVA BN 59 Argatroban 59 Protexia ® 59 trivalent influenza vaccine 59 BENLYSTA ® 59 Cethromycin 59 NASDAQ HGSI 59 G#DT 59 Imvamune R 58 GRNVAC1 58 Pandemic Influenza Vaccine 58 immunotherapeutic vaccine 58 SynCon 58 VivaGel ™ 58 TransVax ™ 58 H#N# antigen 58 Alferon LDO 58 chickenpox varicella 58 VXGN 58 Gamunex C 58 Biocryst 58 recombinant protective 58 adjuvanted H#N# 58 rPA vaccine 58 ricin toxin botulinum toxin 58 Vaxfectin 58 Nasal Powder 58 Elusys 58 oral antiviral 58 vaccine LAIV 58 trivalent seasonal flu 58 Maribavir 58 non nucleoside HCV 58 AMEX RGN 58 StaphVAX R 58 Vaccine Adjuvant 58 MVA BN ® 58 rPA Anthrax Vaccine 58 DermaVir 57 ABthrax TM raxibacumab 57 intranasal influenza 57 virosome 57 investigational hepatitis B 57 anthrax tularemia 57 Kosan dependence 57 Aflunov 57 Proellex TM 57 recombinant subunit vaccine 57 YONDELIS 57 GeoVax AIDS vaccine 57 Neugene 57 Sunesis Pharma 57 Japanese Encephalitis vaccine 57 Civacir 57 live attenuated influenza 57 NASDAQ CGEN announced 57 Files Investigational 57 Muraglitazar 57 Panzem R NCD 57 Lenocta 57 NEUMUNE 57 Virosome Biologicals 57 HepaGam B 57 Silodosin 57 Government Qualifying Therapeutic 57 Allovectin 7 57 Vaxfectin TM formulated 57 BioThrax R 57 thiazolides 57 TransVax TM 57 Miraculins Announces 57 BioThrax 57 Nascobal ® 57 pharmacokinetic PK study 57 Keryx Biopharma 57 Inc. AMEX PIP 57 SparVax TM 57 immune modulatory 56 NASDAQ REGN 56 MBRX 56 TRACON Pharmaceuticals 56 telomerase therapeutic 56 IDIX 56 DepoVax TM 56 Alnylam Nasdaq ALNY 56 forodesine 56 COLAZAL R 56 ketolide antibiotic 56 radezolid 56 Valopicitabine 56 SparVax ™ 56 rPA vaccine candidate 56 biodefense countermeasure 56 Aflibercept 56 vectored vaccine 56 Modified Vaccinia Ankara MVA 56 DYAX 56 NASDAQ NVAX 56 NASDAQ VICL 56 liposomal formulation 56 anti CD3 monoclonal 56 Vaxfectin R formulated 56 H#N# VLP vaccine 56 MBMI Closes 56 Aganocide 56 Alinia 56 IXIARO 56 IAP inhibitors 56 viral subtypes 56 Medical Countermeasure 56 FOLOTYN ® 56 daptomycin 56 TCAD therapy 56 TSRX 56 Ceflatonin R 56 Tezampanel 56 Listeria vaccine 56 BioThrax ® 56 Altastaph 56 Iomai Corporation 56 NASDAQ BPAX 56 Regeneron Pharma 56 Systemic Delivery 56 Archexin 55 NIH NIAID 55 elvucitabine 55 Inc. NASDAQ GNVC 55 ACHN 55 GLP toxicology studies 55 NGSX 55 Orapred ODT 55 Gleevec imatinib mesylate 55 Inc. NASDAQ XNPT 55 Orphan Drug designations 55 Protectan 55 Potelligent Technology 55 OTCBB ADXS 55 Respiratory Syncytial Virus RSV 55 serogroup B 55 SHP.L 55 Aeolus Pharmaceuticals 55 defensin mimetic antibiotic 55 Streptococcus pneumonia 55 adenoviral vectors 55 Hedgehog antagonist 55 recombinant biopharmaceutical 55 Alimera Sciences Inc 55 GTOP 55 Trubion Pharmaceuticals TRBN 55 phosphatidylserine PS targeting 55 SinuNase ™ 55 NASDAQ PGNX 55 SIGA Technologies Inc. 55 Nasdaq ACHN 55 investigational smallpox vaccine 55 Cleveland Biolabs 55 Fc fusion protein 55 rPA 55 NVAX 55 Harry Palmin President 55 antibiotic resistant bacterial infections 55 NASDAQ AVNR 55 HCD# [002] 55 Alnylam Pharma 55 Fodosine 55 biotherapeutic drugs 55 IMMU 55 OTCBB NNVC 55 Dalbavancin 55 Valortim 55 replicon 55 Avanir Pharmaceuticals Inc 55 Valortim ® 55 ZGEN 55 ARQL 55 OGXI 55 CEQ# 55 PSDV 55 Eurand NV EURX 55 please visit http:/www.atherogenics.com 55 Elvitegravir 55 initiated Phase 1b 54 NYSE Amex PTN 54 Enterobacter cloacae 54 SGXP 54 Kaketsuken 54 ZFP Therapeutics 54 novel immunotherapies 54 VRUS 54 carbapenem 54 Temsirolimus 54 Convertible Promissory Note 54 TBC M4 54 Inovio Pharmaceuticals 54 PHRM 54 CIP TRAMADOL ER 54 Influenza Vaccine 54 smallpox anthrax botulism 54 NASDAQ ARRY 54 anti botulism antibody 54 DPX Survivac 54 Inspire Pharma 54 BPAX 54 anthrax plague 54 RiVax ™ 54 GSK '# 54 Project BioShield Act 54 Shigamabs ® 54 HBV vaccine 54 Valortim R 54 LGND 54 Nasdaq SGEN 54 SynCon ™ 54 Panacos Pharmaceuticals 54 Exelixis XL# 54 torezolid phosphate 54 monoclonal antibody mAb 54 Dacogen TM 54 OvaRex ® MAb 54 Abiraterone acetate 54 Iloperidone 54 anthrax ricin 54 BioDelivery Sciences 54 Diamyd ® 54 Vical VICL 54 therapeutic monoclonal antibodies 54 Surfaxin LS 54 Trubion Pharma 54 Integrated Preclinical 54 Vicuron Pharmaceuticals 54 human rhinovirus HRV 54 ZIOP 54 DVAX 54 Peer Reviewed Medical 54 AdVac ® 54 simplex virus 54 diphtheria tetanus pertussis 54 Adenosine Therapeutics 54 Tuberculosis Vaccine 54 Vernakalant 54 Qualified Therapeutic Discovery 54 DynPort Vaccine Company 54 Onconase 54 BioNumerik 54 CDAD Clostridium difficile 54 Immunomedics Inc 54 Phase Ib II 54 Enhanze 54 HuCAL antibodies 54 Plicera 54 RIGScan CR 54 CBLI 54 Akorn Inc 54 Inc. Nasdaq IMGN 54 tularemia infections 54 OvaRex R 54 Nasdaq RDEA 54 anticancer therapeutics 53 immunotherapeutics 53 Isis Pharma 53 Idenix Pharmaceuticals 53 BioDelivery 53 prophylactic vaccines 53 PNT# 53 live attenuated vaccines 53 Mipomersen 53 cardio renal 53 Ebola SNALP 53 AMEX AIS 53 varicella zoster virus VZV 53 faropenem 53 novel antiviral therapeutics 53 TLR9 agonists 53 anticoagulant reversing agent 53 Virulizin ® 53 recombinant polyclonal antibodies 53 Extensively Drug Resistant Tuberculosis 53 L BLP# 53 OSI Pharma 53 Peregrine Pharma 53 proteasome inhibitor 53 BioCryst Pharma 53 CRXL 53 RiVax TM 53 Cephalon NASDAQ CEPH 53 Archemix Corp. 53 Milestone Payment 53 GeoVax HIV AIDS 53 Trubion Pharmaceuticals 53 Siga Technologies 53 AUXL 53 NSTK 53 nasal powder 53 Elusys Therapeutics 53 ARRY # 53 NTDDS 53 Project QTDP program 53 MDR Gram negative 53 Novel Vaccine 53 Cyclacel Pharmaceuticals 53 HHS BARDA 53 Juvaris BioTherapeutics 53 ANIK 53 TRBN 53 therapeutic monoclonal antibody 53 Daclizumab 53 SBIR Grant 53 ONCY 53 compound PMX # 53 ASONEP 53 NRGN 53 tubulin inhibitor 53 AMEX PIP 53 huC# DM4 53 Somatuline Autogel 53 Twinrix 53 Increlex TM 53 OncoVEX 53 Bacillus anthracis anthrax 53 Nabi HB Intravenous 53 adrenergic regulation 53 ATL/TV# 53 VivaGel TM 53 GNVC 53 Protalix BioTherapeutics 53 IMGN 53 Janus kinase 53 NASDAQ IMGN 53 recombinant influenza 53 HQK 53 gastro intestinal inflammation 53 ATL# [001] 53 Ebola Vaccine 53 Tesmilifene 53 AMEX HEB 53 Cytomegalovirus CMV 53 Vaccine Diphtheria CRM# Protein 53 corticosteroid dexamethasone 53 glucokinase activator 53 PDE4 inhibitor 53 ARDM 53 SAR# [004] 53 Optimer Pharmaceuticals Inc 53 NLTX 53 biodefense vaccines 53 antigen sparing 53 Palatin Technologies Inc. 53 Multimeric 53 NASDAQ INFI 53 tiapamil 53 Phase 1b Clinical Trial 53 orally dosed 53 Cellmid 53 Migenix 53 NASDAQ AVII 53 Epiphany Biosciences 53 Mucosal 53 Genvec 53 selectively inhibit replication 53 vaccine adjuvants 52 intranasal vaccines 52 NPC 1C 52 PANC 52 Xcellerex FlexFactory 52 Gord Froehlich President 52 Camvia 52 ONTY 52 Smallpox vaccines 52 Emergent BioSolutions 52 BCRX 52 SHPGY 52 JAK inhibitor 52 NYSE Amex PBTH 52 PATH MVI 52 DCCR 52 Ebola Marburg 52 biomedical countermeasures 52 Vertex Pharmaceuticals Inc 52 Tolamba 52 AMEX PLX 52 hemorrhagic fever viruses 52 ASX PGL 52 PharmaSwiss SA 52 Ziopharm 52 GENR 52 Sequella 52 Michael Fonstein 52 Auxilium Pharma 52 Emergent Biosolutions 52 Inc. OTCBB MBCI 52 Viral Immunotherapy platform 52 CMV vaccine 52 Quark Pharmaceuticals 52 elotuzumab 52 Onalta 52 siRNA therapeutics 52 antitoxins 52 AEterna 52 Epidermal Growth Factor Receptor 52 WRAIR 52 trastuzumab DM1 T DM1 52 Syntiron 52 RNVS 52 Idenix Pharmaceuticals Inc 52 NASDAQ LGND 52 NASDAQ PANC 52 subunit vaccine 52 GelSite polymer 52 sorafenib tablets small 52 Sigma Tau Pharmaceuticals 52 Restanza 52 Idenix Pharma 52 Bicifadine 52 ImmunoCellular Therapeutics 52 lixivaptan 52 Ridaforolimus 52 Cleveland BioLabs Inc. 52 ALNY 52 TLR9 agonist 52 AkaRx 52 Antibody Discovery 52 NASDAQ SGEN 52 Targretin capsules 52 PRTX 52 tuberculosis hepatitis B 52 Protectan CBLB# 52 Incyte Corp 52 NASDAQ SIGA 52 Ibis T# 52 TSX VENTURE COT 52 EndoBiologics 52 AMEX ONI 52 topical anti infective 52 bioscavenger 52 A5 Labs 52 Cypress Bioscience Inc 52 Ampligen 52 RECOTHROM R 52 ONCONASE R 52 developing TB4 52 OHR/AVR# 52 Daniel J. Abdun 52 Sanofi pasteur 52 AEGR 52 therapeutic peptide 52 PREVENAR 52 NEUGENE 52 plague tularemia 52 attenuated strain 52 LEAPS TM 52 NASDAQ ENMD 52 NOVAVAX 52 toxoid 52 recombinant vaccines 52 NASDAQ DYAX 52 Nasdaq RXII 52 HCV protease inhibitors 52 DepoVax 52 IV APAP 52 EPCT 52 Cancer Vaccines 52 PEGylated interferon 52 CRTX 52 ImmunoVaccine Technologies 52 VICL 52 Nasdaq CGEN 52 LGLS 52 REGN 52 Quark Biotech 52 Factor VIIa 52 NovaBay Aganocide compounds 52 VitiGam 52 Oncothyreon Inc 52 Shigamabs 52 Peregrine Pharmaceuticals 52 targeting CD# 52 MF# adjuvanted 52 Smallpox vaccine 52 Bezielle 52 MAXY G# 51 Maxy G# 51 Halozyme Therapeutics 51 PROLOR Biotech Inc. 51 Immunotherapeutics 51 Progenics Pharmaceuticals 51 CBLB# 51 Chimigen TM 51 pDNA vaccines 51 Enzon Pharmaceuticals Inc 51 Cellerant 51 NASDAQ INGN 51 Phase IIb clinical trials 51 Inc. OTCBB SYBD 51 celgosivir 51 Adenovirus 51 Calixa Therapeutics 51 programs visit http:/www.nih.gov/ 51 adenovector 51 influenza VLP vaccine 51 Meritage Pharma 51 Protalix BioTherapeutics PLX 51 NASDAQ AEZS 51 NYSE Amex SVA 51 atacicept 51 MRNA 51 Dr. Vitetta 51 Æterna Zentaris 51 Humanetics 51 AnGes MG Inc. 51 Genocea Biosciences 51 Aerosurf 51 ZIOPHARM Oncology 51 OncoGenex Pharmaceuticals Inc. 51 AMEX CVM 51 NASDAQ VRTX 51 Ramoplanin 51 biologic therapeutics 51 MEDX 51 Universal Flu Vaccine 51 OPTR 51 MKC# MKC# PP 51 NASDAQ CBLI 51 cathepsin K inhibitor 51 HuLuc# 51 Project Bioshield 51 MOGN 51 Discovery Project QTDP 51 Ercole Biotech 51 HDAC Inhibitor 51 NYMX 51 Senesco Technologies 51 ATHX 51 molecular chaperone regulation 51 IMA# 51 Voraxaze 51 RSV prophylaxis 51 Icatibant 51 preclinical toxicology 51 NASDAQ OSIR 51 Pimavanserin 51 FLUPAN 51 GelSite 51 SCLN 51 GlaxoSmithKline plc GSK 51 Oscient Pharmaceuticals 51 KOSN 51 GelVac TM 51 Septin 9 51 Tarvacin Anti Viral 51 CRXX 51 Ariad Pharma 51 ARIKACE ™ 51 JAK2 inhibitor 51 Nektar Therapeutics NKTR 51 cGMP manufacture 51 Anticancer Agents 51 serotypes strains 51 Hemispherx Biopharma 51 SVNT 51 tetravalent vaccine 51 immunotoxins 51 Alton Boynton 51 OTCBB AFLB 51 Celgosivir 51 b Hib 51 Immuron 51 prostone 51 Bought Deal Financing 51 Tarvacin TM 51 SynCon ™ DNA 51 Roche OTC RHHBY 51 BMRN 51 histone deacetylase HDAC 51 Supernus Pharmaceuticals 51 JNJ Q2 51 Tarvacin 51 IRS Qualifying Therapeutic 51 Berna Biotech AG 51 KNS # 51 DynPort 51 Ventrus 51 NASDAQ ENZN 51 Momenta Pharmaceuticals MNTA 51 AnorMED expectation 51 sanofi aventis SNY 51 Nasdaq HGSI 51 Javelin Pharmaceuticals 51 PHARMACEUTICALS INC. 51 Viropharma 51 INCY 51 DRRX 51 Nabi Pharmaceuticals 51 Galenea 51 VCRT 51 Biosante 51 PrevOnco 51 BNVI 51 Tobira Therapeutics 51 Radilex 51 AFRRI 51 PWRM.OB 51 Zeneus 50 Progenics Pharmaceuticals Inc 50 Santarus NASDAQ SNTS 50 Idera Pharmaceuticals 50 PANVAC VF 50 vivo validation 50 attenuated weakened 50 OTCBB CTIX 50 ALN RSV# 50 Radient Pharma 50 A3 adenosine receptor 50 adeno associated viruses 50 DepoVax ™ 50 ENTB 50 ACADIA Pharmaceuticals 50 Frova ® 50 GTCB 50 NNVC 50 Corixa Corporation 50 Nasdaq OPTR 50 Seattle Genetics SGEN 50 AMEX RNN 50 A5 Laboratories 50 novel peptides 50 Chemokine 50 Million Convertible Debt 50 TPIV 50 Nasdaq SIGA 50 NASDAQ ONXX 50 eniluracil 50 Genelabs Technologies 50 Homspera TM 50 OSIP 50 KV.A 50 CBLC# 50 RXII 50 oncolytic viruses 50 Sunesis Pharmaceuticals 50 Nanotechnology Characterization Laboratory 50 OPXA 50 IDEV 50 Coley Pharmaceutical Group 50 Regeneron Pharmaceuticals Inc 50 NASDAQ BCRX 50 Penwest Pharmaceuticals 50 EV# vaccine 50 Vegenics 50 NicVAX 50 Immunomedics Inc. 50 Inc. Amex SYI 50 Shire plc SHPGY 50 RNAi therapeutic platform 50 UGNE 50 IND submission 50 KL4 Surfactant 50 ADXS 50 Fibrillex 50 Nascobal 50 PBME 50 NBIX 50 Ebola vaccine 50 Cellpep 50 Actilon 50 Indevus Pharma 50 virology immunology 50 NEPH 50 TTHI 50 Protalix BioTherapeutics Inc. 50 GVAX Pancreas Vaccine 50 DelSite Biotechnologies 50 CureDM 50 GNBT 50 CRME 50 Nasdaq PARD 50 Medical Countermeasures 50 FURX 50 NanoViricides 50 Lorus Therapeutics 50 NASDAQ FLML 50 ALTH 50 AutovaxID 50 humanized monoclonal antibodies 50 ELTP 50 Novelos Therapeutics 50 THRX 50 VTUS 50 Alexza Pharmaceuticals Inc 50 Compugen NASDAQ CGEN 50 PBTH 50 Nasdaq ACAD 50 ixabepilone 50 Nymox Pharmaceutical 50 methylnaltrexone 50 Offering Quick Facts 50 RDEA 50 Cleveland BioLabs 50 Scancell 50 REGENERX BIOPHARMACEUTICALS INC. 50 address untreatable bioterror 50 Vaccinex 50 Inc NGSX 50 Neogenix 50 OPi 50 R pegaptanib sodium 50 Menactra vaccine 50 VaxInnate 50 CDDO Im 50 Monoclonal Antibodies 50 Cepheid CPHD 50 SBIR Contract 50 THLD 50 Peptimmune 50 Onyx Pharmaceuticals Inc 50 Luna Innovations Announces 50 Enzon Pharmaceuticals 50 Vertex Pharma 50 Accentia Biopharmaceuticals 50 DispersinB ® 50 ENZN 50 radiation countermeasure 50 Corlux 50 Emisphere Technologies 50 protective antigen 50 CLDX 49 Vical Incorporated Nasdaq VICL 49 ToxCast TM 49 Nanotherapeutics 49 MNTA 49 Arrow Therapeutics 49 FMD vaccines 49 Omeros Corporation 49 drug conjugate 49 anthrax botulinum toxin 49 TTNP 49 RIGScan 49 Project QTDP 49 Million Unsecured 49 Infectious Disease NIAID 49 Optimer Pharmaceuticals 49 ECTE 49 Inc. NASDAQ ZLCS 49 variola 49 AVI BioPharma 49 RegeneRx Biopharmaceuticals Inc. 49 EpiTherapeutics 49 MyVax 49 Qualifying Therapeutic Discovery 49 HEPH 49 Biosante Pharmaceuticals 49 F. tularensis 49 CELGENE 49 Etubics 49 Million Non Brokered 49 NEUGENE antisense 49 GlaxoSmithKline Biologicals 49 Cathepsin S 49 Therion Biologics 49 SGLT 49 Initial Purchasers 49 AMEX INO 49 AlphaVax 49 commercializing anti infective 49 Nasdaq OMER 49 HepeX B 49 tkRNAi 49 HspE7 49 NovaBay Pharmaceuticals 49 OSUR 49 Pharmos Corporation 49 Alvine Pharmaceuticals 49 PEGylated 49 Transformational Medical 49 Inc. NASDAQ DSCO 49 NASDAQ APPY 49 MenACWY CRM 49 Medicilon 49 Panacos Pharmaceuticals Inc. 49 KaloBios 49 Entremed 49 Bellicum Pharmaceuticals Inc. 49 NASDAQ OPXA 49 BiondVax 49 BARDA 49 Durect 49 NASDAQ ZIOP 49 RAPTIVA r 49 herpes simplex viruses 49 immunomodulator 49 Curaxin 49 Calixa 49 PHEMCE 49 Lexicon Pharmaceuticals 49 Keryx Biopharmaceuticals 49 Profectus BioSciences 49 antiviral therapeutics 49 Spectrum Pharmaceuticals SPPI 49 next generation URAT1 49 Allergy Cardiovascular 49 SRDX 49 Response Biomedical 49 NVLT 49 DispersinB R 49 AFFY 49 Ariad Pharmaceuticals 49 PEG SN# 49 Conatus Pharmaceuticals 49 RGDX 49 Flamel Technologies 49 Synta Pharma 49 Crucell PER.C6 ® 49 Alexion Pharma 49 Enobia 49 Excelimmune 49 ARYX 49 intranasal vaccine 49 Immunogen IMGN 49 Targacept TRGT 49 epigenetic therapies 49 Generex Biotechnology 49 Symphony Icon 49 Nastech Pharmaceutical Company 49 zoster vaccine 49 Vantex Completes 49 BACcel 49 OTCBB CVBT 49 Nektar pulmonary 49 Acambis PLC 49 PTIE 49 TACI Ig 49 PER.C6 r 49 VLP vaccine 49 DAIDS 49 rifamycins 49 MZEI 49 Nobilon 49 GSK # 49 TolerRx 49 Theravance THRX 49 Pneumococcus 49 ganetespib 49 Array BioPharma ARRY 49 Malaria Vaccine Initiative 49 ZFP Therapeutic 49 BSL3 49 Research WRAIR 49 XmAb# 49 NSPH 48 ZTEST Announces 48 ABII 48 NASDAQ ARIA 48 ImmuneWorks 48 Ligand Pharmaceuticals NASDAQ LGND 48 Polymer Microspheres 48 Capsulution 48 Transfection Reagent 48 DynPort Vaccine 48 Cellgate 48 PharmaBio 48 NASDAQ OMER 48 Neutralizing antibodies 48 DOS# 48 AirIQ Announces 48 CYTX 48 Ardea Biosciences 48 Trubion Pharmaceuticals Inc. 48 Virdante 48 Non Dilutive 48 Non Brokered Financing 48 pandemic influenza vaccine 48 NASDAQ AMLN 48 GNLB 48 RGEN 48 Vaccinia 48 NASDAQ ACHN 48 Optimer Pharmaceuticals Inc. 48 bioterror agents 48 NASDAQ GNTA 48 VRX# [001] 48 SUPG 48 NOVN 48 Vion Pharmaceuticals 48 AMEX ANX 48 AVRX 48 ALN RSV program 48 DXL TM 48 Immunomedics IMMU 48 Alnylam ALNY 48 GTHP 48 Ception 48 Biotie 48 REP# 48 trivalent vaccine 48 Valeant Pharma 48 Nasdaq CBLI 48 WILEX 48 Selecta Biosciences 48 BULM 48 OSI Pharmaceuticals OSIP 48 genetically attenuated 48 Vijay B. Samant 48 Infections Diseases 48 RDYN 48 Altus Pharmaceuticals 48 anthrax botulism 48 Avanir Pharma 48 Dr. Ellen Vitetta 48 Stapled Peptide 48 traunch 48 oncolytic virus 48 ABIO 48 anthrax vaccine 48 Closes Flow Through 48 Valeant Pharmaceuticals VRX 48 BioMarin Pharma 48 Rocmec Closes 48 LentiVector technology 48 TRGT 48 Vanda Pharmaceuticals Inc 48 photodisinfection 48 DCTH 48 Arno Therapeutics 48 RNAi therapeutic 48 Genzyme nasdaq GENZ 48 Monoclonal 48 otelixizumab 48 viral hemorrhagic fevers 48 Inovio Pharmaceuticals Inc. 48 MLNM 48 Infectious Diseases USAMRIID 48 NASDAQ PANC biotechnology 48 LEAD Therapeutics 48 REVENUE BONDS SERIES 48 preclinical efficacy 48 TNGN 48 HCV antiviral 48 smallpox anthrax 48 IGXT IntelGenx today 48 Ligand Pharmaceuticals Incorporated 48 Juergen Engel Ph.D. 48 Cellular Immunology 48 prophylactic vaccine 48 RPRX 48 BioTie 48 EXAS 48 HTS assay 48 Oncogenex

Back to home page